Japan health ministry board approves Novavax's COVID-19 vaccine

A Japanese Health Ministry committee said on Monday it has approved Novavax Inc's COVID-19 vaccine, setting the stage for full approval of the country's fourth shot for the coronavirus.

Biocon Biologics to raise $1.2 billion offshore loan for Viatris deal

Biocon Biologics, a unit of Biocon, is raising $1.2 billion via an offshore loan with the pharmaceutical company likely appointing HSBC, MUFG and Standard Chartered Bank to underwrite the proposed five-year overseas loan, two sources familiar...

Ocugen acquired Covaxin to commercialise rights for all of North America

OcugenInc and Bharat Biotech declared that they have entered into an amendment to their co-development, supply and commercialisation agreement to expand Ocugen’s exclusive territory to include commercialisation of Covaxin in Mexico.

CCI confirm deal to acquire minority stake in BDR Pharmaceuticals

The Competition Commission of India approves acquisition of minority stake of BDR Pharmaceuticals International Private Limited (BDR/Target) by Multiples Private Equity Fund III, SRF Transnational Holdings Limited (SRF Transnational)...

QOL Medical selects Optum Frontier Therapies as pharmacy collaborates to support CSID patients on Sucraid oral solution

QOL Medical, LLC, a ground-breaking rare disease pharmaceutical firm, has selected Optum Frontier Therapies as its new pharmacy partner to support CSID patients nationwide being treated with Sucraid (sacrosidase) oral solution.

Omicron-specific Sinopharm & Sinovac Covid vaccine candidates cleared for clinical trail

COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong, the firms said on Saturday.

How Blockchain can Revolutionize Pharmaceutical Industry

The digital transformation has brought many technologies for the industries that help to enhance organisations’ performance, transparency and security levels.

Sandoz introduces generic brimonidine tartrate/timolol maleate eyedrop in US market

Sandoz, a global leader in generic and biosimilar medicines, declared the US launch of its generic combination eyedrop brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%, an AB-rated generic equivalent to AbbVie’s Combigan...

Two shot vaccine of Zydus gets SEC nod

Soon a two-shot Covid-19 vaccine of Zydus Cadila could be rolled out, instead of the three-shot regimen currently approved.

Britain accepts Moderna's COVID shot for 6-11 year-olds

Britain's medicines regulator on Thursday permitted the use of Moderna's COVID-19 vaccine in children between six and 11 years, as the country bolsters itself for fighting coronavirus infections amid the spread of new virus variants.

© 2025 India Pharma Outlook. All Rights Reserved.